Home
About
Services
Partners
Client Portfolio
News
Contact
Apple reports higher sales as China reopens after coronavirus but gives no forecast
April 30, 2020
Amazon’s second-quarter forecast weighed down by $4 billion in COVID-19 related costs, shares fall
April 30, 2020
0
Gilead aims to expand remdesivir output for COVID-19, posts flat 1st-quarter results
Published by
Muller&Green
at
April 30, 2020
Categories
RSS
Tags
Gilead Sciences Inc , maker of the experimental coronavirus drug remdesivir, on Thursday said it will work with international partners to expand production of the potential COVID-19 treatment.
Powered by
WPeMatico
Muller&Green
Related posts
December 17, 2024
Five Lessons From My Mentor
Read more
December 13, 2024
Where Does Corporate Climate Action Go Next?
Read more
December 12, 2024
CEO of the Year Lisa Su Talks Competition and Collaboration in the Semiconductor Industry
Read more